Company / Return on Assets (ROA)
Crinetics Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-41.3%
FY2025
5-year range
-46.5% / -20.8%
FY2021-FY2025
Trend
-98.7%
vs FY2024
Sector context
#160 of 213
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s return on assets (roa) of -41.3% is lower than 75% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -58.7% in FY2017 to -3.5% in FY2018.
Based on SEC 10-K filings.
-41.3% in FY2025 with a 5-year CAGR of -26.5%.
Declined from -33.8% to -41.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +5.2pp
- 5-Year Change
- -26.5pp
- 10-Year Change
- -
Sector benchmark
-71.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 98.7% year-over-year.
- Currently 17.2pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -41.3% | -98.7% |
| FY2024 | -20.8% | +38.4% |
| FY2023 | -33.8% | +27.4% |
| FY2022 | -46.5% | -51.7% |
| FY2021 | -30.7% | -107.5% |
| FY2020 | -14.8% | -110.5% |
| FY2019 | -7.0% | -100.0% |
| FY2018 | -3.5% | +94.0% |
| FY2017 | -58.7% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026